Celon Pharma SA
WSE:CLN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
Celon Pharma SA
WSE:CLN
|
PL |
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CLN's stock price target?
Price Target
18.36
PLN
According to Wall Street analysts, the average 1-year price target for CLN is 18.36 PLN with a low forecast of 16.16 PLN and a high forecast of 22.79 PLN.
What is the Revenue forecast for Celon Pharma SA?
Projected CAGR
13%
Over the last 9 years, the compound annual growth rate for Revenue has been 7%. The projected CAGR for the next 5 years is 13%.
What is the Gross Profit forecast for Celon Pharma SA?
Projected CAGR
-16%
Over the last 9 years, the compound annual growth rate for Gross Profit has been 6%. The projected CAGR for the next 4 years is -16%.